Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Public ClinicalTrials.gov record NCT03412643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage HER2-Negative Breast Cancer Patients Selected With a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1)
Study identification
- NCT ID
- NCT03412643
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NSABP Foundation Inc
- Network
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Celcuity CELx HSF Diagnostic Test
- Cyclophosphamide Drug
- Doxorubicin Drug
- Pertuzumab Drug
- Trastuzumab Drug
- Weekly Paclitaxel Drug
Diagnostic Test · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 13, 2018
- Primary completion
- Oct 29, 2023
- Completion
- Oct 29, 2023
- Last update posted
- Mar 5, 2023
2018 – 2023
United States locations
- U.S. sites
- 43
- U.S. states
- 17
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arrowhead Regional Medical Center | Colton | California | 92324 | Recruiting |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | Recruiting |
| University of Florida Cancer Center at Orlando Health | Orlando | Florida | 32806 | Recruiting |
| Cancer Care Specialists of Central Illinois | Decatur | Illinois | 62526 | Recruiting |
| Edward Hospital Cancer Center | Naperville | Illinois | 60540-7499 | Recruiting |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46804 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| University of Louisville JG Brown Cancer Center | Louisville | Kentucky | 40202 | Recruiting |
| University Medical Center New Orleans | New Orleans | Louisiana | 70112 | Recruiting |
| Greater Baltimore Medical Center | Baltimore | Maryland | 21204 | Recruiting |
| St. Joseph Mercy Hospital | Ann Arbor | Michigan | 48106 | Recruiting |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Recruiting |
| Genesys Hurley Cancer Institute | Flint | Michigan | 48503 | Recruiting |
| Herbert Herman Cancer Center, Sparrow Hospital | Lansing | Michigan | 48912 | Recruiting |
| Ascension St. Mary's | Saginaw | Michigan | 48601 | Recruiting |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | Recruiting |
| University of Rochester - Wilmot Cancer Institute | Rochester | New York | 14642 | Recruiting |
| Strecker Cancer Center-Belpre | Belpre | Ohio | 45714 | Recruiting |
| Aultman Hospital | Canton | Ohio | 44710 | Recruiting |
| Cleveland Clinic Taussig Cancer Center | Cleveland | Ohio | 44195 | Recruiting |
| Arthur G. James Cancer Hospital & Richard Solove Research Institute | Columbus | Ohio | 43210 | Recruiting |
| Columbus Oncology & Hematology Associates Inc | Columbus | Ohio | 43214 | Recruiting |
| The Mark H. Zangmeister Center | Columbus | Ohio | 43219 | Recruiting |
| Doctors Hospital | Columbus | Ohio | 43228 | Recruiting |
| Adena Regional Medical Center | Columbus | Ohio | 45601 | Recruiting |
| Dayton Clinical Oncology Program | Dayton | Ohio | 45420 | Recruiting |
| Dayton Physicians LLC | Dayton | Ohio | 45420 | Recruiting |
| Delaware Health Center | Delaware | Ohio | 43015 | Recruiting |
| Marietta Memorial Hospital Cancer Center | Marietta | Ohio | 45750 | Recruiting |
| Marion General Hospital | Marion | Ohio | 43303 | Recruiting |
| Knox Community Hospital | Mount Vernon | Ohio | 43050 | Recruiting |
| Licking Memorial Hospital | Newark | Ohio | 43055 | Recruiting |
| Southern Ohio Medical Center | Portsmouth | Ohio | 45662 | Recruiting |
| Genesis Health Care | Zanesville | Ohio | 43701 | Recruiting |
| Wellspan Health - York Cancer Center | York | Pennsylvania | 17403 | Recruiting |
| Harris Health Systems-Smith Clinic | Houston | Texas | 77030 | Recruiting |
| Lester and Sue Smith Breast Center | Houston | Texas | 77030 | Recruiting |
| Centra Lynchburg Hematology Oncology | Lynchburg | Virginia | 24501 | Recruiting |
| Bon Secours Richmond Community Hospital Medical Oncology Assoc. | Mechanicsville | Virginia | 23116 | Recruiting |
| Bon Secours St. Francis Medical Center | Midlothian | Virginia | 23114 | Recruiting |
| Bon Secours Richmond Community Hospital at St. Mary's | Richmond | Virginia | 23226 | Recruiting |
| West Virginia University | Morgantown | West Virginia | 26506 | Recruiting |
| Ascension St. Elizabeth Hospital | Appleton | Wisconsin | 54915 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03412643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03412643 live on ClinicalTrials.gov.